natgillin/translations-raw huggingface dataset:
The other ingredients for Nimvastid 1.5 mg capsules are microcrystalline cellulose, hypromellose, colloidal anhydrous silica, magnesium stearate in the capsule content, and titanium dioxide (E171), yellow iron oxide (E172) and gelatine in the capsule shell.
Drugi sastojci za Nimvastid 1,5 mg kapsule su mikrokristalična celuloza, hipromeloza, koloidni bezvodni silicijev dioksid i magnezijev stearat u sadržaju kapsule i titanijev dioksid (E171), žuti željezov oksid (E172) i želatina u ovojnici kapsule.
The other ingredients for Nimvastid 3 mg, 4.5 mg and 6 mg capsules are microcrystalline cellulose, hypromellose, colloidal anhydrous silica, magnesium stearate in the capsule content, and titanium dioxide (E171), yellow iron oxide (E172), red iron oxide (E172) and gelatine in the capsule shell.
Drugi sastojci za Nimvastid 3 mg, 4,5 mg i 6 mg kapsule su mikrokristalična celuloza, hipromeloza, koloidni bezvodni silicijev dioksid i magnezijev stearat u sadržaju kapsule i titanijev dioksid (E171), žuti željezov oksid (E172), crveni željezov oksid (E172) i želatina u ovojnici kapsule.
The other ingredients in Ambirix are: sodium chloride and water for injections.
Drugi sastojci cjepiva Ambirix su: natrijev klorid i voda za injekcije.
The other ingredients in Fendrix are: sodium chloride, water for injections.
Drugi sastojci u cjepivu Fendrix su: natrijev klorid, voda za injekcije.
The other ingredients in the 200 mg and 400 mg tablets are: hypromellose, macrogol 400, magnesium stearate, microcrystalline cellulose, polysorbate 80, povidone (K30), sodium starch glycolate (type A), titanium dioxide (E171).
Drugi sastojci u tabletama od 200 i 400 mg su: hipromeloza, makrogol 400, magnezijev stearat, mikrokristalična celuloza, polisorbat 80, povidon (K30), natrijev škrobolikolat (vrste A), titanijev dioksid (E171).
The other ingredients in the concentrate are anhydrous ethanol, all-rac-α-tocopherol (E 307), propylene glycol and anhydrous citric acid (E 330).
Drugi sastojci u koncentratu su bezvodni etanol, all-rac-α-tokoferol (E 307), propilenglikol i bezvodna citratna kiselina (E 330).
The other ingredients in the concentrate are: anhydrous ethanol, all-rac-α-tocopherol (E 307), propylene glycol and anhydrous citric acid (E 330).
Pomoćne tvari u koncentratu su: bezvodni etanol, all-rac-α-tokoferol (E 307), propilenglikol i bezvodna citratna kiselina (E 330).
The other ingredients in the film-coating are: hypromellose (E464), macrogol, lactose monohydrate (see section 2 under »Dasselta contains lactose«.), titanium dioxide (E171) and indigo carmine (E132).
Drugi sastojci u film ovojnici su hipromeloza (E464), makrogol, laktoza hidrat (vidjeti dio 2 pod „Dasselta sadrži laktozu“), titanijev dioksid (E171) i indigotin (E132).
The other ingredients in the powder are citric acid monohydrate (E330), trehalose dihydrate, lysine hydrochloride, polysorbate 80, and sodium hydroxide.
Drugi sastojci u prašku su citratna kiselina hidrat (E330), trehaloza dihidrat, lizinklorid, polisorbat 80 i natrijev hidroksid.
The other ingredients in the powder are polysorbate 80, sodium chloride (see also section 2), calcium chloride dihydrate, sucrose, Tris base, Tris HCl, Tri-sodium citrate dihydrate.
Drugi sastojci praška su polisorbat 80, natrijev klorid (vidjeti i dio 2), kalcijev klorid dihidrat, saharoza, Tris baza, Tris HCl, Tri-natrijev citrat dihidrat.
The other ingredients in the powder are sodium chloride, calcium chloride dihydrate, glycylglycine, polysorbate 80, mannitol, sucrose, methionine, hydrochloric acid, sodium hydroxide.
Drugi sastojci u prašku su natrijev klorid, kalcijev klorid dihidrat, glicilglicin, polisorbat 80, manitol, saharoza, metionin, kloridna kiselina, natrijev hidroksid.
The other ingredients in the powder are sucrose, mannitol, sodium chloride, calcium chloride, L-histidine, polysorbate 80.
Drugi sastojci praška su saharoza, manitol, natrijev klorid, kalcijev klorid, L-histidin, polisorbat 80.
The other ingredients in the suspension are polysorbate 80, simeticone, sodium benzoate (E211), sodium citrate dihydrate, citric acid monohydrate, glycerol, xanthan gum, liquid glucose, titanium dioxide (E171), artificial cherry flavour containing benzyl alcohol and propylene glycol, and purified water.
Pomoćne tvari u suspenziji su polisorbat 80, simetikon, natrijev benzoat (E112), natrijev citrat dihidrat, citratna kiselina hidrat, glicerol, ksantanska guma, tekuća glukoza, titanijev dioksid (E171), umjetna aroma trešnje koja sadrži benzilni alkohol i propilenglikol, i pročišćena voda.
The other ingredients in the tablet are croscarmellose sodium, hyprolose, magnesium stearate, microcrystalline cellulose, sodium laurilsulfate.
Drugi sastojci tablete su umrežena karmelozanatrij, hiproloza, magnezijev stearat, mikrokristalična celuloza, natrijev laurilsulfat.
The other ingredients in the tablet are lactose monohydrate, microcrystalline cellulose (E460i), povidone, sodium starch glycolate Type A, magnesium stearate (E572), polysorbate 80 (E433), polyvinyl alcohol (E1203), titanium dioxide (E171), talc (E553b), soya lecithin (E322), and xanthan gum (E415).
Drugi sastojci u tableti su laktoza hidrat, mikrokristalična celuloza (E460i), povidon, natrijev škroboglikolat vrsta A, magnezijev stearat (E572), polisorbat 80 (E433), poli(vinilni alkohol) (E1203), titanijev dioksid (E171), talk (E553b), sojin lecitin (E322) i ksantanska guma (E415).
The other ingredients in the tablet core are (see section 2 ‘Clopidogrel Teva Pharma B.V. contains lactose’ and ‘Clopidogrel Teva Pharma B.V. contains hydrogenated castor oil’) lactose monohydrate, microcrystalline cellulose, hydroxypropylcellulose (E463), crospovidone (type A), hydrogenated castor oil and sodium laurilsulfate, and in the film-coating are lactose monohydrate, hypromellose (E464), titanium dioxide (E171), macrogol 4000, iron oxide red (E172), iron oxide yellow (E172), indigo carmine aluminium lake (E132).
i Klopidogrel Teva Pharma B.V. hidrogenirano ricinusovo ulje) laktoza hidrat, mikrokristalična celuloza, hidroksipropilceluloza (E463), krospovidon (tip A), hidrogenirano ricinusovo ulje i natrijev laurilsulfat, te u ovojnici tablete: laktoza hidrat, hipromeloza (E464), titanijev dioksid (E171), makrogol 4000, crveni željezov oksid (E172), žuti željezov oksid (E172) i indigo carmine aluminium lake (E132)
The other ingredients in the tablet core are cellulose microcrystalline, povidone, starch pregelatinised, magnesium stearate and in the film-coating are poly(vinyl alcohol), talc, titanium dioxide (E171), macrogol, iron oxide yellow (E172), lecithin (soya), iron oxide red (E172).
Drugi sastojci u jezgri tablete su mikrokristalična celuloza, povidon, prethodno geliran škrob, magnezijev stearat, a u ovojnici tablete poli(vinilni alkohol), talk, titanijev dioksid (E171), makrogol, žuti željezov oksid (E172), sojin lecitin, crveni željezov oksid (E172)
The other ingredients in the tablet core are croscarmellose sodium, magnesium stearate, maize starch, mannitol (E421) and povidone (E1201)
Drugi sastojci u jezgri tablete su umrežena karmelozanatrij, magnezijev stearat, kukuruzni škrob, manitol (E 421) i povidon (E 1201).
The other ingredients in the tablet core are croscarmellose sodium, magnesium stearate, maize starch, mannitol (E421) and povidone (E1201)
Drugi sastojci u jezgri tablete su umrežena karmelozanatrij, magnezijev stearat, kukuruzni škrob, manitol (E421) i povidon (E1201).
The other ingredients in the tablet core are croscarmellose sodium, magnesium stearate, maize starch, mannitol (E421) and povidone (E1201).
Drugi sastojci u jezgri tablete su umrežena karmelozanatrij, magnezijev stearat, kukuruzni škrob, manitol (E 421) i povidon (E 1201).
The other ingredients in the tablet core are croscarmellose sodium, magnesium stearate, maize starch, mannitol (E421) and povidone (E1201).
Drugi sastojci u jezgri tablete su umrežena karmelozanatrij, magnezijev stearat, kukuruzni škrob, manitol (E421) i povidon (E1201).
The other ingredients in the tablet core are hypromellose (E464), maize starch, crospovidone (E1202), poloxamer 407, lactose monohydrate, colloidal anhydrous silica, magnesium stearate (E572).
Pomoćne tvari u jezgri tablete su: hipromeloza (E464), kukuruzni škrob, krospovidon (E1202), poloksamer 407, laktoza hidrat, bezvodni koloidni silicijev dioksid, magnezijev stearat (E572).
The other ingredients in the tablet core are maize starch, pregelatinised starch, sodium starch glycollate, povidone, glycerol dibehenate and magnesium stearate.
Druge sastojci u jezgri tablete su kukuruzni škrob, prethodno gelirani škrob, natrijev škroboglikolat, povidon, gliceroldibehenat i magnezijev stearat.
The other ingredients in the tablet core are maize starch, pregelatinised starch, sodium starch glycollate, povidone, glycerol dibehenate and magnesium stearate.
Drugi sastojci u jezgri tablete su kukuruzni škrob, prethodno gelirani škrob, natrijev škroboglikolat, povidon, gliceroldibehenat i magnezijev stearat.
The other ingredients in the tablet core are microcrystalline cellulose, croscarmellose sodium, povidone and magnesium stearate.
Drugi sastojci su mikrokristalična celuloza, umrežena karmelozanatrij, povidon, i magnezijev stearat.
The other ingredients in the tablet core are microcrystalline cellulose, lactose monohydrate, croscarmellose sodium and magnesium stearate.
Drugi sastojci jezgre tablete su mikrokristalična celuloza, laktoza hidrat, umrežena karmelozanatrij i magnezijev stearat.
The other ingredients in the tablet core are microcrystalline cellulose, low-substituted hydroxypropylcellulose, crospovidone, magnesium stearate, talc and silica colloidal anhydrous.
Drugi sastojci u jezgri tablete su mikrokristalična celuloza, niskosupstituirana hidroksipropilceluloza, krospovidon, magnezijev stearat, talk i silicijev dioksid koloidni bezvodni.
The other ingredients in the tablet core are: lactose monohydrate, magnesium stearate (E 470 B), maize starch, maltodextrin, colloidal anhydrous silica (E 551), and in the tablet coating: hypromellose (E 464), titanium dioxide (E 171), macrogol 6000, glycerol (E 422), magnesium stearate (E 470 B), yellow iron oxide (E 172), red iron oxide (E 172).
Pomoćne tvari u jezgri tablete su: laktoza hidrat, magnezijev stearat (E 470 B), kukuruzni škrob, maltodekstrin, bezvodni koloidni silicijev dioksid (E 551); a u ovojnici tablete: hipromeloza (E 464), titanijev dioksid (E 171), makrogol 6000, glicerol (E 422), magnezijev stearat (E 470 B), žuti željezov oksid (E 172), crveni željezov oksid (E 172).
The other ingredients in the tablet core are: microcrystalline cellulose (E460), hypromellose (E464), hydrochloric acid (E507), sodium hydroxide (E524), maize starch, lactose monohydrate (see section 2 under »Dasselta contains lactose«.) and talc (E553b).
Drugi sastojci u jezgri tablete su mikrokristalična celuloza (E460), hipromeloza (E464), kloridna kiselina (E507), natrijev hidroksid (E524), kukuruzni škrob, laktoza hidrat (vidjeti dio 2 pod „Dasselta sadrži laktozu“) i talk (E553b).
The other ingredients in the tablet film coating are iron oxide black, iron oxide red, macrogol 3350, poly(vinyl alcohol), talc, titanium dioxide.
Drugi sastojci film ovojnice tablete su crni željezov oksid, crveni željezov oksid, makrogol 3350, poli(vinilni alkohol), talk, titanijev dioksid.
The other ingredients in the vaccine suspension are sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride and water for injections.
Drugi sastojci u suspenziji cjepiva su natrijev dihidrogenfosfat, natrijev hidrogenfosfat, natrijev klorid i voda za injekcije.
The other ingredients in the vaccine suspension are:
Drugi sastojci suspenzije cjepiva su:
The other ingredients in the vaccine suspension are: sodium chloride, L-histidine, polysorbate 80, sodium borate and water for injections.
Drugi sastojci suspenzije cjepiva su: natrijev klorid, L-histidin, polisorbat 80, natrijev borat i voda za injekcije.
The other ingredients in this medicine are povidone K29/32, sodium starch glycolate type A and magnesium stearate.
Drugi sastojci ovog lijeka su povidon K29/32, natrijev škroboglikolat tipa A i magnezijev stearat.
The other ingredients in this medicine are povidone K29/32, sodium starch glycolate type A, glucose liquid (spray dried), erythrosine (E127), titanium dioxide (E171), aspartame (E951), tutti frutti flavour (contains sorbitol), carmellose sodium, hydroxyethylcellulose.
Drugi sastojci ovog lijeka su povidon K29/32, natrijev škroboglikolat tipa A, raspršina tekuće glukoze, eritrozin (E127), titanijev dioksid (E171), aspartam (E951), tutti frutti okus (sadrži sorbitol), karmelozanatrij, hidroksietilceluloza.
The other ingredients in Twinrix Adult are: sodium chloride, water for injections.
Drugi sastojci u cjepivu Twinrix Adult su: natrijev klorid, voda za injekcije.
The other ingredients in Twinrix Paediatric are: sodium chloride, water for injections.
Drugi sastojci u cjepivu Twinrix Paediatric su: natrijev klorid, voda za injekcije.
The other ingredients ingredients are:
Drugi sastojci su:
The other ingredients of the capsule are
Drugi sastojci kapsule su
The other ingredients of the capsule are caprylocaproyl macrogol-8 glycerides, butylhydroxyanisole (E320), and butylhydroxytoluene (E321).
Drugi sastojci kapsule su kaprilokaproil makrogol-8 gliceridi, butilhidroksianizol (E320) i butilhidroksitoluen (E321).
The other ingredients of the film-coated tablet core are lactose monohydrate, croscarmellose sodium, povidone K30, polysorbate 20, silicified microcrystalline cellulose and magnesium stearate.
Pomoćne tvari u jezgri filmom obložene tablete su laktoza hidrat, umrežena karmelozanatrij, povidon K30, polisorbat 20, silicirana mikrokristalična celuloza i magnezijev stearat.
The other ingredients of the inhalation powder are lactose monohydrate and magnesium stearate.
Drugi sastojci praška inhalata su laktoza hidrat i magnezijev stearat.
The other ingredients of the oral solution are sorbitol, propylene glycol, sucralose E 955, hypromellose 2910, sodium citrate dihydrate, natural and artificial flavour (bubblegum), citric acid anhydrous, disodium edetate and purified water.
Drugi sastojci oralne otopine su sorbitol, propilenglikol, sukraloza (E955), hipromeloza 2910, natrijev citrat dihidrat, prirodna i umjetna aroma (žvakaća guma), bezvodna citratna kiselina, dinatrijev edetat i pročišćena voda.
The other ingredients of the powder are polysorbate 20, sucrose, sodium dihydrogen phosphate monohydrate, disodium phosphate dihydrate, concentrated phosphoric acid, sodium hydroxide, L-methionine and nitrogen.
Drugi sastojci praška su polisorbat 20, saharoza, natrijev dihidrogenfosfat hidrat, natrijev hidrogenfosfat dihidrat, koncentrirana fosfatna kiselina, natrijev hidroksid, L-metionin i dušik.
The other ingredients of the powder are: alanine, mannitol, disodium phosphate dodecahydrate, disodium phosphate dihydrate, sodium dihydrogen phosphate dihydrate.
Pomoćne tvari u prašku su: alanin, manitol, natrijev hidrogenfosfat dodekahidrat, natrijev hidrogenfosfat dihidrat i natrijev dihdrogenfosfat dihidrat.
The other ingredients of the powder are: cherry flavour, methylhydroxybenzoate (E218), propylhydroxybenzoate (E216), silicon dioxide, simethicone, sodium carmellose, sorbic acid, stearate emulsifiers and sucrose.
Pomoćne tvari praška su: okus trešnje, metilhidroksibenzoat (E218), propilhidroksibenzoat (E216), silicijev dioksid, simetikon, karmeloza natrij, sorbatna kiselina, stearatni emulgator i saharoza.
The other ingredients of the powder contained in the hard capsule are: lactose (180 mg), magnesium stearate, microcrystalline cellulose and sodium starch glycolate.
Pomoćne tvari praška sadržane u tvrdoj kapsuli su: laktoza (120 mg), magnezijev stearat, mikrokristalična celuloza i natrijev škroboglikolat.
The other ingredients of the powder contained in the hard capsule are: lactose (240 mg), magnesium stearate, microcrystalline cellulose and sodium starch glycolate.
Pomoćne tvari praška sadržane u tvrdoj kapsuli su: laktoza (120 mg), magnezijev stearat, mikrokristalična celuloza i natrijev škroboglikolat.
The other ingredients of the solvent are: poloxamer 188, water for injection.
Pomoćne tvari u otapalu su: poloksamer 188 i voda za injekciju.
The other ingredients of the tablet are calcium hydrogen phosphate dihydrate, microcrystalline cellulose, maize starch, talc.
Drugi sastojci su kalcijev hidrogenfosfat dihidrat, mikrokristalična celuloza, kukuruzni škrob, talk.
The other ingredients of the tablet core are: croscarmellose sodium, microcrystalline cellulose, sodium laurilsulfate, hydroxypropylcellulose, lactose monohydrate and magnesium stearate.
Drugi sastojci u jezgri tablete su: umrežena karmelozanatrij, mikrokristalična celuloza, natrijev laurilsulfat, hidroksipropilceluloza, laktoza hidrat i magnezijev stearat.
The other ingredients of the tablets are:
Pomoćne tvari u tableti su:
The other ingredients that are present in the 25 mg, 50 mg, and 100 mg orodispersible tablets are: fish gelatin, mannitol (E421), aspartame (E951), and orange flavour.
Drugi sastojci koji se nalaze u raspadljivim tabletama za usta od 25 mg, 50 mg i 100 mg: riblja želatina, manitol (E421), aspartam (E951) i aroma naranče.
The other ingredients that are present in the 300 mg orodispersible tablets are: bovine gelatin, mannitol (E421), aspartame (E951), and orange flavour.
Drugi sastojci koji se nalaze u raspadljivim tabletama za usta od 300 mg: goveđa želatina, manitol (E421), aspartam (E951) i aroma naranče.
The other ingredients that are present in the capsule contents are: microcrystalline cellulose, hydrogenated vegetable oil and sodium laurilsulfate.
Drugi sastojci koje sadrži kapsula: mikrokristalična celuloza, hidrogenirano biljno ulje i natrijev laurilsulfat.
The other main measure of effectiveness, used in one study, was the improvement in the patient’s ability to carry out everyday tasks (such as dressing, eating, and walking) after 24 weeks.
Druga glavna mjera djelotvornosti, primijenjena u jednom ispitivanju, bila je poboljšanje sposobnosti bolesnika da izvodi svakodnevne zadatke (poput oblačenja, jedenja i hodanja) nakon 24 tjedna.
The other main study involved 502 patients with advanced melanoma that had not been previously treated.
Drugo glavno ispitivanje obuhvatilo je 502 bolesnika s uznapredovalim melanomom koji prethodno nije liječen.
The other most commonly reported adverse reactions included upper respiratory tract infections (8.4%), headache (7.9%), and tension headache (7.2%).
Druge najčešće prijavljene nuspojave uključivale su infekcije gornjih dišnih puteva (8,4%), glavobolju (7,9%) i tenzijsku glavobolju (7,2%).
The other most frequently reported adverse reactions were keratitis and foreign body sensation in eyes which occurred in 0.5% and 0.3% of patients, respectively both adverse reactions with a frequency category of uncommon.
Ostale najčešće zabilježene nuspojave bile su keratitis i osjećaj stranog tijela u oku , a koje su se pojavile u 0,5% odnosno 0,3% bolesnika, obje nuspojave unutar kategorije učestalosti manje često.
The other nine deaths among those treated with SIRTURO occurred after completion of treatment with this agent (range 86-911 days post-SIRTURO; median 344 days).
Preostalih devet smrtnih slučajeva među onima koji su liječeni lijekom SIRTURO dogodilo se nakon završetka liječenja tim lijekom (raspon 86-911 dana nakon lijeka SIRTURO; medijan 344 dana).
The other side effects that have been experienced by some patients taking Actos are: common (may affect up to 1 in 10 people)
Ostale nuspojave koje su osjetili neki bolesnici koji uzimaju Actos su: često (mogu se pojaviti u do 1 na 10 osoba)
The other side effects that have been experienced by some patients taking Glustin are: common (may affect up to 1 in 10 people)
Ostale nuspojave koje su osjetili neki bolesnici koji uzimaju Glustin su: često (mogu se pojaviti u do 1 na 10 osoba)
The other side effects that have been experienced by some patients taking Paglitaz are: common (may affect up to 1 in 10 people)
Ostale nuspojave koje su osjetili neki bolesnici koji uzimaju Paglitaz su: često (mogu se javiti u do 1 na 10 osoba)
The other side effects that have been experienced by some patients taking Pioglitazone Accord are: common (may affect up to 1 in 10 people)
Ostale nuspojave koje su osjetili neki bolesnici koji uzimaju Pioglitazone Accord su: često (mogu se pojaviti u od 1 do 10 na 100 osoba)
The other side effects that have been experienced by some patients taking Pioglitazone Krka are: common (may affect up to 1 in 10 people)
Ostale nuspojave koje su osjetili neki bolesnici koji uzimaju Pioglitazone Krka su: često (mogu se javiti u do 1 na 10 osoba)
The other side of the tablet debossed with number “7465”.
Na drugoj strani tablete je utisnut broj "7465".
The other side of the tablet debossed with number “7466”.
Na drugoj strani tablete je utisnut broj "7466".
The other side of the tablet is debossed with the number "7458".
Na drugoj strani tablete je utisnut broj "7458".
The other side of the tablet is debossed with the number "7459".
Na drugoj strani tablete utisnut je broj "7459".
The other side of the tablet is debossed with the number "7460".
Na drugoj strani tablete je utisnut broj "7460".
The other side of the tablet is debossed with the number "7460".
Na drugoj strani tablete utisnut je broj "7460".
The other strengths of Levetiracetam tablets do not contain this ingredient.
Druge jačine Levetiracetam tableta me sadrže ovaj sastojak.
The other strengths of Matever tablets do not contain this ingredient.
Druge jačine Matever tableta ne sadrže ovaj sastojak.
The other study (456 patients) compared Bydureon with insulin glargine as add-on treatment to metformin with or without a sulphonylurea.
Drugo ispitivanje (456 bolesnika) usporedilo je lijek Bydureon s inzulinom glarginom kao dodatnim liječenjem u liječenju metforminom sa sulfonilurejom ili bez nje.
The other study compared Ristaben with metformin, used on their own, in 1,058 patients; three additional studies compared Ristaben with placebo when they were added to other diabetes medicines: glimepiride (another sulphonylurea), with or without metformin, in 441 patients; the combination of metformin and rosiglitazone (a PPAR-gamma agonist) in 278 patients; and a stable dose of insulin, with or without metformin, in 641 patients.
Drugo je ispitivanje usporedilo Ristaben s metforminom, koji su korišteni kao monoterapije u 1058 bolesnika; tri dodatna ispitivanja usporedila su Ristaben s placebom kada su dodani drugim lijekovima za dijabetes: glimepirid (druga sulfonilureja), s ili bez metformina, u 441 bolesnika; kombinacija metformina i rosiglitazona (agonista PPAR-gama) u 278 bolesnika; stabilna doza inzulina, s ili bez metformina u 641 bolesnika.
The other study, which compared RoActemra injected under the skin with RoActemra given by infusion, showed that RoActemra injected under the skin was no less effective in achieving a response after 6 months.
Drugim ispitivanjem, tijekom kojega je lijek RoActemra primijenjen injekcijom pod kožu uspoređen s lijekom RoActemra primijenjenim u obliku infuzije, pokazalo se da lijek RoActemra kada se daje injekcijom pod kožu nije manje učinkovit s obzirom na odgovor nakon šest mjeseci.
The other subject used 24.6 IU/kg once weekly for 8.5 months.
Drugi ispitanik koristio je 24,6 IU/kg jednom tjedno tijekom 8,5 mjeseci.
The other tablet ingredients are: copovidone, sorbitan laurate, anhydrous calcium hydrogen phosphate, colloidal anhydrous silica, sodium stearyl fumarate.
Drugi sastojci u tableti su: kopovidon, sorbitanlaurat, bezvodni kalcijev hidrogenfosfat, bezvodni, koloidni silicijev dioksid, natrijev stearilfumarat.
The other three studies involved a total of 743 patients who had taken treatment for HIV infection before: the first two compared Reyataz, taken with saquinavir (another antiviral medicine) but without ritonavir, with ritonavir-boosted saquinavir or ritonavir-boosted lopinavir.
Ostala su tri ispitivanja obuhvatila ukupno 743 bolesnika koji su prethodno primali terapiju za liječenje infekcije HIV-om: u prva dva ispitivanja Reyataz je ispitan uz istodobnu primjenu sakvinavira (drugi antivirusni lijek), ali bez primjene ritonavira, no uz primjenu sakvinavira ojačanog ritonavirom ili lopinavira ojačanog ritonavirom.